NCT02304367 2024-05-06Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)Kyowa Kirin Co., Ltd.Phase 2 Completed17 enrolled 66 charts
NCT03510455 2021-04-08BGJ398 for the Treatment of Tumor-Induced OsteomalaciaNational Institutes of Health Clinical Center (CC)Phase 2 Terminated4 enrolled 28 charts